S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit Podcast Por  arte de portada

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

S1E4 - SGLT-2 Inhibitors Morning Commute: Widening Benefit

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

Visit http://morningcommutepodcast.com/SGLT2inhibitors4 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.

Todavía no hay opiniones